PARAMUS, N.J.--(BUSINESS WIRE)--PsychoGenics Inc. (PsychoGenics) today announced it has been awarded a contract by the National Institutes of Health (NIH) to test and identify novel investigational ...

Please provide your email address to receive an email when new articles are posted on . A phase 2 human challenge trial will measure time to recovery from dengue and determine effective doses of the ...

The National Institutes of Health’s flagship long COVID initiative, RECOVER—short for Researching COVID to Enhance Recovery—has after a year of deliberation selected several drug candidates to test as ...

Researchers with NIH say they’ve found proteins in blood that accurately detect ALS long before symptoms emerge. The study findings could help with early detection, definitive testing, and tracking ...

The National Institutes of Health has launched a proof-of-concept precision medicine clinical trial to test new treatment combinations targeting specific genetic changes in the cancer cells of people ...

DeepSeek, a blood test that can detect HPV-linked head and neck cancers nearly a decade before diagnosis. By finding viral DNA in the bloodstream, the test achieved 99% sensitivity and specificity.